---
title: "Corporate Pivots Accelerate: Pure Storage Rebrands as Securitize Pushes RWA Tokenization"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298310976.md"
description: "A diverse group of US-listed micro and mid-caps are undergoing significant structural changes in 2026. Everpure's solid USD 1.1 billion quarterly revenue and Securitize's regulatory advances highlight a wave of strategic repositioning."
datetime: "2026-09-08T11:32:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298310976.md)
  - [en](https://longbridge.com/en/news/298310976.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298310976.md)
generator: "portal-rs"
---

# Corporate Pivots Accelerate: Pure Storage Rebrands as Securitize Pushes RWA Tokenization

A wave of corporate restructuring, acquisitions, and clinical milestones is sweeping through a distinct basket of US-listed mid and micro-caps in 2026.

Enterprise storage heavyweight **Everpure (PSTG.US)**—formerly Pure Storage—is showing clear financial momentum. Fresh off its agreement to acquire 1touch for enhanced data orchestration, the company posted USD 1.1 billion in Q4 FY26 revenue, up 20% year-over-year, alongside USD 616 million in annual free cash flow. In the semiconductor space, **Mobix Labs (MOBX.US)** is expanding via its acquisition of drone maker Vision Aerial, guiding for an approximate 100% sequential revenue jump to the midpoint of USD 1.6 million in Q4 2026, bolstered by a fresh Gulfstream production order.

The digital asset and real-world asset (RWA) sectors are experiencing a regulatory shakeup. **Securitize Holdings (SECZ.US)**, which listed on the NYSE in July, reported USD 14.4 million in Q2 2026 revenue and just inked a pact with Dubai's Virtual Assets Regulatory Authority to advance tokenized markets. Crypto-fintech firm **Antalpha Platform Holding (ANTA.US)** is pivoting, announcing a strategic expansion into AI infrastructure. Conversely, digital asset and DNA firm **BNB Plus (BNBX.US)** hit a snag, facing a Nasdaq delisting and a move to the OTCQB market in July.

Biotech developments and alternative funding vehicles continue to surface. **Erasca (ERAS.US)** secured FDA Fast Track designation in August for its ERAS-0015 pancreatic cancer therapy, while **Tyra Biosciences (TYRA.US)** is prepping to read out preliminary Phase II SURF302 trial results in September. On the capital structuring side, the GE Vernova 2x leveraged ETF **GEVX (GEVX.US)** has been active since July 2025. Blank-check firm **Galaxyedge Acquisition (GLED.US)** and Hong Kong-based IoT provider **Mega Fortune (MGRT.US)** round out the group, navigating the choppy waters of post-IPO positioning.

### Related Stocks

- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)
- [ANTA.US](https://longbridge.com/en/quote/ANTA.US.md)
- [PSTG.US](https://longbridge.com/en/quote/PSTG.US.md)
- [BNBX.US](https://longbridge.com/en/quote/BNBX.US.md)
- [TYRA.US](https://longbridge.com/en/quote/TYRA.US.md)
- [SECZ.US](https://longbridge.com/en/quote/SECZ.US.md)
- [MGRT.US](https://longbridge.com/en/quote/MGRT.US.md)
- [MOBX.US](https://longbridge.com/en/quote/MOBX.US.md)
- [GLED.US](https://longbridge.com/en/quote/GLED.US.md)

## Related News & Research

- [Mega Fortune Company Limited GAAP EPS of -$0.25, revenue of $0.52M](https://longbridge.com/en/news/300557663.md)
- [Oppenheimer reiterates Outperform rating on Tyra Biosciences, $40 price target](https://longbridge.com/en/news/299797255.md)
- [Tyra Bioscience Director Makes Bold Insider Move That Could Signal Big Things Ahead](https://longbridge.com/en/news/298782816.md)
- [Securitize tokenized AUM rises 9% to USD 4.3 billion as of June 30](https://longbridge.com/en/news/295705505.md)
- [TYRA: Oral dabogratinib achieved 79% ORR and 64% CR in Phase 2 LG IR NMIBC, supporting Phase 3 plans](https://longbridge.com/en/news/298447575.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**